Hospital Acquired Infections Diagnostics Market Size Report, 2032

Hospital Acquired Infections (HAI) Diagnostics Market - By Product (Reagents, Analyzers), By Test Type (Traditional Diagnostic Test, Molecular Diagnostic Assay, Immunoassays, Mass Spectrometry), By Infection Type, By End-use, & Forecast, 2023 – 2032 

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data Sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Hospital acquired infections (HAI) diagnostics industry 3600&nbsp;synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Product trends

2.5&nbsp;&nbsp;&nbsp; Test type trends

2.6&nbsp;&nbsp;&nbsp; Infection type trends

2.7&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Hospital Acquired Infections (HAI) Diagnostics Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing prevalence of hospital acquired infections (HAI)

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancements

3.2.1.3&nbsp;&nbsp;&nbsp;Rising demand for point-of-care (POC) testing

3.2.1.4&nbsp;&nbsp;&nbsp;Growing demand for early diagnosis and prevention of hospital acquired diseases

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory policies

3.2.2.2&nbsp;&nbsp;&nbsp;Lack of awareness regarding hospital acquired infections in low and middle income nations

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By test type

3.3.3&nbsp;&nbsp;&nbsp; By infection type

3.3.4&nbsp;&nbsp;&nbsp; By end use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Pricing analysis, 2022

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6.1&nbsp;&nbsp;&nbsp; U.S.

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.7&nbsp;&nbsp;&nbsp; Technology landscape

3.8&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.9&nbsp;&nbsp;&nbsp; Future market trends

3.10&nbsp;&nbsp;&nbsp; Gap analysis

3.11&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.12&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Vendor matrix analysis, 2022

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast, By Product (USD Million &amp; Units)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Reagents

5.3&nbsp;&nbsp;&nbsp; Analyzers

Chapter 6&nbsp;&nbsp;&nbsp;Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast, By Test Type (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by test type

6.2&nbsp;&nbsp;&nbsp; Traditional Diagnostic Test

6.3&nbsp;&nbsp;&nbsp; Molecular Diagnostic Assay

6.4&nbsp;&nbsp;&nbsp; Immunoassays

6.5&nbsp;&nbsp;&nbsp; Mass Spectrometry

6.6&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast, By Infection Type (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by infection type

7.2&nbsp;&nbsp;&nbsp; Urinary Tract Infections (UTIs)

7.3&nbsp;&nbsp;&nbsp; Surgical Site Infections (SSIs)

7.4&nbsp;&nbsp;&nbsp; Respiratory Infections

7.5&nbsp;&nbsp;&nbsp; Bloodstream Infections

7.6&nbsp;&nbsp;&nbsp; Gastrointestinal Infections

7.7&nbsp;&nbsp;&nbsp; Others

Chapter 8&nbsp;&nbsp;&nbsp;Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast, By End-use (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Diagnostic Laboratories

8.4&nbsp;&nbsp;&nbsp; Research Institutes

8.5&nbsp;&nbsp;&nbsp; Others

Chapter 9&nbsp;&nbsp;&nbsp;Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast, By Region (USD Million &amp; Units)

9.1&nbsp;&nbsp;&nbsp; Key trends, by region

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Poland

9.3.7&nbsp;&nbsp;&nbsp; Sweden

9.3.8&nbsp;&nbsp;&nbsp; The Netherlands

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; Japan

9.4.2&nbsp;&nbsp;&nbsp; China

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Thailand

9.4.7&nbsp;&nbsp;&nbsp; Indonesia

9.4.8&nbsp;&nbsp;&nbsp; Philippines

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.5.4&nbsp;&nbsp;&nbsp; Columbia

9.5.5&nbsp;&nbsp;&nbsp; Chile

9.5.6&nbsp;&nbsp;&nbsp; Peru

9.6&nbsp;&nbsp;&nbsp; MEA

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Israel

9.6.5&nbsp;&nbsp;&nbsp; Turkey

9.6.6&nbsp;&nbsp;&nbsp; Iran

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

10.2&nbsp;&nbsp;&nbsp; Bayer

10.3&nbsp;&nbsp;&nbsp; Becton Dickinson And Company

10.4&nbsp;&nbsp;&nbsp; Biom&eacute;rieux

10.5&nbsp;&nbsp;&nbsp; Danaher Corporation

10.6&nbsp;&nbsp;&nbsp; Ecolab

10.7&nbsp;&nbsp;&nbsp; Hologic, Inc.

10.8&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson

10.9&nbsp;&nbsp;&nbsp; Merck

10.10&nbsp;&nbsp;&nbsp; Pfizer Inc.

10.11&nbsp;&nbsp;&nbsp; Roche

10.12&nbsp;&nbsp;&nbsp; Siemens Healthcare

10.13&nbsp;&nbsp;&nbsp; Steris Plc

10.14&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

&nbsp;&nbsp;&nbsp;

Hospital Acquired Infections HAI Diagnostics Market

Get a free sample of this report